title: Suggestive evidence for a new locus for epilepsy with heterogeneous phenotypes on chromosome 17q.
abstract: OBJECTIVE
  To characterize the clinical features and molecular genetic background in a family with various epilepsy phenotypes including febrile seizures, childhood absence epilepsy, and possible temporal lobe epilepsy.
  
  
  METHODS
  Clinical data were collected. DNA and RNA were extracted from peripheral blood. A genome-wide microsatellite marker scan was performed and regions with a multipoint location score > or =1.5 were fine mapped. Functional candidate genes identified from databases and by comparing gene expression profiles of genes between affected and unaffected individuals were sequenced. Copy number variation was evaluated with array-based comparative genomic hybridization.
  
  
  RESULTS
  The seizure phenotype was benign. Inheritance was consistent with an autosomal dominant model and reduced penetrance. The highest two-point LOD score of 2.8 was identified at marker D17S1606 in a 37cM interval on chromosome 17q12-q24. Loci on 5q11.2 and on 18p11-q11, showed LOD scores > or =1.5 after fine mapping. Sequencing of nine ion-channel genes and two (RPIP8 and SLC25A39) differentially expressed genes from 17q12-q24, as well as IMPA2 from 18p11-q11 did not reveal a pathogenic alteration. No clinically relevant copy number variation was identified.
  
  
  CONCLUSIONS
  Our findings suggest complex inheritance of seizure susceptibility in the family with contribution from three loci, including a possible new locus on chromosome 17q. The underlying molecular defects remain unknown.
authors.affiliation: Department of Pediatrics, Tampere University Hospital, Finland. auli.siren@uta.fi
authors.forename: Auli
authors.initials: A
authors.lastname: Sirén
authors.forename: Anne
authors.initials: A
authors.lastname: Polvi
authors.forename: Lyne
authors.initials: L
authors.lastname: Chahine
authors.forename: Malgorzata
authors.initials: M
authors.lastname: Labuda
authors.forename: Sarah
authors.initials: S
authors.lastname: Bourgoin
authors.forename: Anna-Kaisa
authors.initials: AK
authors.lastname: Anttonen
authors.forename: Maria
authors.initials: M
authors.lastname: Kousi
authors.forename: Kari
authors.initials: K
authors.lastname: Hirvonen
authors.forename: Kalle O J
authors.initials: KO
authors.lastname: Simola
authors.forename: Eva
authors.initials: E
authors.lastname: Andermann
authors.forename: Asta
authors.initials: A
authors.lastname: Laiho
authors.forename: Juhani
authors.initials: J
authors.lastname: Soini
authors.forename: Matti
authors.initials: M
authors.lastname: Koivikko
authors.forename: Reijo
authors.initials: R
authors.lastname: Laaksonen
authors.forename: Massimo
authors.initials: M
authors.lastname: Pandolfo
authors.forename: Anna-Elina
authors.initials: AE
authors.lastname: Lehesjoki
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002874:Chromosome Mapping / Q000379:methods*; D002886:Chromosomes, Human, Pair 17 / Q000235:genetics*; D004252:DNA Mutational Analysis / Q000379:methods; D004827:Epilepsy / Q000145:classification / Q000235:genetics*; D005192:Family Health; D005260:Female; D020869:Gene Expression Profiling / Q000379:methods; D005838:Genotype; D006801:Humans; D007473:Ion Channels / Q000235:genetics; D008126:Lod Score; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D020411:Oligonucleotide Array Sequence Analysis / Q000379:methods; D010641:Phenotype
chemical_list: D007473:Ion Channels